Nernst equation

1,655views

00:00 / 00:00

Nernst equation

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Hepatitis
Pancreatitis: Pathology review
Alcohol-induced liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid dependence
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Breaking down USMLE®-style questions: 4
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Assessments

Flashcards

0 / 13 complete

Flashcards

Nernst equation

0 of 13 complete

Transcript

Watch video only

The Nernst equation helps explain how a Galvanic cell works - so let’s start by drawing out a galvanic cell.

A galvanic cell has two electrodes - so for our example, let’s say there’s one solid zinc electrode and that it’s in a 1.0 molar solution of zinc-two-plus ions, and that there’s a solid copper electrode and it’s in a 1.0 molar solution of copper-two-plus ions.

Now, copper ions turn their solution a blue color, whereas zinc ions don’t color their solution - so it’s colorless.

Since the concentration of both copper and zinc ion solutions is 1.0 molar and if we assume that the temperature is 25 degrees celsius, then we’re under standard conditions.

Now, in our galvanic cell, the two electrodes are connected by a wire with an open switch and there’s also a salt bridge between the two compartments.

The salt bridge allows electrical charge to travel between the two solutions.

To get the galvanic cell started, we need to close the switch, so that electrons or electrical current can flow through the wire.

Now, if we want to calculate the cell potential, or cell voltage, for this zinc-copper cell, we need to use the Nernst equation.

So here’s the Nernst equation, E refers to the instantaneous voltage of the galvanic cell, or the voltage at a specific moment in time.

Enaught or Ezero is a constant called the “standard voltage,” and it’s simply based on the two metals that we’re using in our galvanic cell.

We can look up this number for zinc and copper, and we find that it has a value of +1.10 volts.

N refers to the number of moles of electrons that are transferred during the redox reaction.

Q is the reaction quotient, which is the ratio of the concentration of reactants to the concentration of products in our galvanic cell.

When we calculate this, we only include the concentration of the ions, and we leave out the pure solids like the zinc and copper electrodes. This tells us the progress of the reaction.

Now, we can look at our two half reactions.

Zn(s) --> Zn2+ + 2 e- Cu2+ + 2 e- --> Cu(s)

During the first half-reaction, our solid zinc metal loses two electrons, and during the second half-reaction, the copper ions in solution gain two electrons.

Loss of Electrons is Oxidation, and so the solid zinc electrode is being oxidized to form zinc two plus ions.

Gain of Electrons is Reduction so copper two plus ions are being reduced to form solid copper. Remember that LEO the lion goes GER!

To get the overall equation, we add the two half-reactions together and get solid zinc plus copper two plus ions yields zinc two plus ions and solid copper.

Overall, two moles of electrons are transferred during our redox reaction. So N equals two.

To get Q, we take the concentration of zinc two plus ions divided by the concentration of copper two plus ions.

Since both ion concentrations are 1.0 molar, Q is equal to 1.0 divided by 1.0 which is one.

When we plug all that in to the Nernst equation, we find that the instantaneous voltage is equal to positive 1.10.

The second term in the Nernst equation turns out to be equal to zero, because the logarithm of Q is the logarithm of one, which is zero.

So the instantaneous voltage is equal to the standard voltage.

In this case it’s positive 1.10 volts at the instant when we close the switch.

The reason why this makes sense is because we’re at standard conditions, the ion concentration in both compartments is 1.0 molar.

Now let’s change things up. Let’s keep the zinc ion concentration at 1.0 molar, but increase the copper ion concentration from 1.0 molar to 10.0 molar.

Now we have nonstandard conditions. Let’s calculate Q at the moment that we close the switch.

At that moment, Q equals the concentration of zinc two plus divided by the concentration of copper two plus. So 1.0 divided by 10.0 or 0.10.

We can plug this new Q into the Nernst equation to give us a new instantaneous voltage.

We start with Ezero, which is still positive 1.10 volts.

From this number we next subtract 0.0592 divided by N, times the log of Q.

N is still two, but now the reaction quotient is 0.10.

The log of 0.10 gives us a negative number, which we multiply by 0.0592 divided by 2.

Because this number is negative, we end up adding this number to 1.10 in order to give an instantaneous voltage of positive 1.13 volts.

Notice what’s happened: when Q was equal to 1.0, the voltage was 1.10, and when Q was decreased to 0.10, the voltage increased to 1.13.

So more generally, when you decrease the reaction quotient, you increase the instantaneous voltage.

Now, let’s change things up again. Let’s keep the copper ion concentration at 1.0 molar, but increase the zinc ion concentration from 1.0 molar to 10.0 molar.

So we have nonstandard conditions again. Let’s calculate Q at the moment that we close the switch.

At that moment, Q equals the concentration of zinc two plus divided by the concentration of copper two plus. So 10.0 divided by 1.0, or 10.0.

We can plug this new Q into the Nernst equation to give us a new instantaneous voltage.

We start with Ezero, which is still positive 1.10 volts.

From this number we next subtract 0.0592 divided by N, times the log of Q.

Summary

The Nernst equation is a mathematical relationship that explains how a Galvanic cell works and allows us to find the instantaneous voltage of a cell at a specific moment in time.

Its expression is:

E = E0 - (RT/zF)lnQ

Where:

E is the potential difference across the membrane (in volts) E0 is the equilibrium potential for the ion (in volts) R is the universal gas constant T is the temperature (in Kelvin) z is the charge of the ion F is the Faraday constant Q is the reaction quotient